186 related articles for article (PubMed ID: 1457369)
41. [Establishment of ACNU-resistant rat gliosarcoma cell lines and their characteristics].
Saito Y; Hotta T; Mikami T; Kurisu K; Kawamoto K; Kiya K; Uozumi T
Neurol Med Chir (Tokyo); 1991 Dec; 31(13):846-52. PubMed ID: 1726242
[TBL] [Abstract][Full Text] [Related]
42. Hypersensitivity of rat glioma sublines with acquired ACNU resistance to L-asparaginase.
Saito Y; Nakada Y; Hotta T; Mikami T; Kurisu K; Kiya K; Kawamoto K; Uozumi T
J Neurosurg; 1991 Dec; 75(6):930-4. PubMed ID: 1682427
[TBL] [Abstract][Full Text] [Related]
43. Specific mTOR inhibitor rapamycin enhances cytotoxicity induced by alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU) in human U251 malignant glioma cells.
Tanaka K; Sasayama T; Mizukawa K; Kawamura A; Kondoh T; Hosoda K; Fujiwara T; Kohmura E
J Neurooncol; 2007 Sep; 84(3):233-44. PubMed ID: 17390104
[TBL] [Abstract][Full Text] [Related]
44. [Possibility of overcoming ACNU resistance in ACNU-resistant sublines of rat brain tumors in vitro by a calmodulin inhibitor].
Yoshida T; Shimizu K; Mogami H; Sakamoto Y; Egawa T
No Shinkei Geka; 1987 Feb; 15(2):143-9. PubMed ID: 3470626
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of single-bolus vs. frequent low-dose treatment with nitrosourea in experimental gliomas.
Wu CM; Inamura T; Ikezaki K; Nakamizo A; Inoha S; Yaosaka F; Fukui M
Anticancer Res; 2001; 21(3B):1835-8. PubMed ID: 11497267
[TBL] [Abstract][Full Text] [Related]
46. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
47. Application of antisense ribonucleic acid complementary to O6-methylguanine-deoxyribonucleic acid methyltransferase messenger ribonucleic acid for therapy of malignant gliomas.
Nagane M; Asai A; Shibui S; Nomura K; Kuchino Y
Neurosurgery; 1997 Aug; 41(2):434-40; discussion 440-1. PubMed ID: 9257312
[TBL] [Abstract][Full Text] [Related]
48. [Circumvention of ACNU-resistance in rat glioma cells by pretreatment with O6-methylguanine].
Mineura K; Fushimi S; Sasaki J; Sasajima H; Ishino Y; Kowada M
Gan To Kagaku Ryoho; 1989 Feb; 16(2):259-62. PubMed ID: 2919893
[TBL] [Abstract][Full Text] [Related]
49. Neurotoxicity and pharmacokinetics of intrathecal perfusion of ACNU in dogs.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Inoue N; Sueyoshi N; Uemura S; Ushio Y
Cancer Res; 1990 May; 50(10):3119-23. PubMed ID: 2334907
[TBL] [Abstract][Full Text] [Related]
50. [Meningeal gliomatosis--clinical features and results of treatment].
Arita N; Hayakawa T; Mogami H; Ushio Y
Gan No Rinsho; 1989 Sep; 35(11):1308-12. PubMed ID: 2478733
[TBL] [Abstract][Full Text] [Related]
51. Distribution of intrathecally administered ACNU in mongrel dogs: pharmacokinetics and quantitative autoradiographic study.
Hori T; Tanaka S; Nishiyama M; Kamitani H; Watanabe T; Tabuchi F; Tatsuhara T; Nakajima E
Surg Neurol; 1993 Sep; 40(3):183-95. PubMed ID: 8346472
[TBL] [Abstract][Full Text] [Related]
52. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T
Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903
[TBL] [Abstract][Full Text] [Related]
53. Gene expression profiles of 1-(4-amino-2-methyl-5-pyrimidinyl)-methyl-3-(2-chloroethyl)-3-nitrosourea (ACNU)-resistant C6 rat glioma cells.
Nakagawa T; Kubota T; Ido K; Sakuma T; Matsuda K
J Neurooncol; 2006 Sep; 79(3):271-9. PubMed ID: 16645721
[TBL] [Abstract][Full Text] [Related]
54. Sensitivity to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) of glioma cells in vivo and in vitro.
Yoshida J; Shibuya N; Kobayashi T; Kageyama N
Cancer; 1982 Aug; 50(3):410-8. PubMed ID: 6953989
[TBL] [Abstract][Full Text] [Related]
55. Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat.
Kooistra KL; Rodriguez M; Powis G; Yaksh TL; Harty GJ; Hilton JF; Laws ER
Cancer Res; 1986 Jan; 46(1):317-23. PubMed ID: 3753551
[TBL] [Abstract][Full Text] [Related]
56. Experimental study of intraoperative local chemotherapy with fibrin glue containing nitrosourea for malignant gliomas.
Kabuto M; Kubota T; Kobayashi H; Nakagawa T; Arai Y; Kitai R
Surg Neurol; 1995 Aug; 44(2):151-6; discussion 156-7. PubMed ID: 7502205
[TBL] [Abstract][Full Text] [Related]
57. Modification of tumor blood flow and enhancement of therapeutic effect of ACNU on experimental rat gliomas with angiotensin II.
Tokuda K; Abe H; Aida T; Sugimoto S; Kaneko S
J Neurooncol; 1990 Jun; 8(3):205-12. PubMed ID: 2358853
[TBL] [Abstract][Full Text] [Related]
58. Intra-arterial ACNU therapy for malignant brain tumors. Experimental studies and preliminary clinical results.
Yamashita J; Handa H; Tokuriki Y; Ha YS; Otsuka SI; Suda K; Taki W
J Neurosurg; 1983 Sep; 59(3):424-30. PubMed ID: 6577143
[TBL] [Abstract][Full Text] [Related]
59. [Distribution of ACNU in the rat brain after intracisternal injection--macroscopical autoradiographic study].
Huang TY; Arita N; Ushio Y; Hayakawa T; Nagatani M; Mogami H
No To Shinkei; 1987 Mar; 39(3):263-6. PubMed ID: 3472532
[TBL] [Abstract][Full Text] [Related]
60. [Possibility of overcoming of ACNU resistance in an ACNU-resistant subline of C6 rat glioma].
Yoshida T; Shimizu K; Ushio Y; Mogami H; Sakamoto Y
No To Shinkei; 1986 Nov; 38(11):1065-70. PubMed ID: 3468959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
